<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101287856</journal-id>
<journal-id journal-id-type="pubmed-jr-id">33885</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Protoc Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Protoc Cell Biol</journal-id>
<journal-title-group>
<journal-title>Current protocols in cell biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1934-2500</issn>
<issn pub-type="epub">1934-2616</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29924488</article-id>
<article-id pub-id-type="pmc">6993937</article-id>
<article-id pub-id-type="doi">10.1002/cpcb.51</article-id>
<article-id pub-id-type="manuscript">NIHMS947196</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcription-factor mediated differentiation of human iPSCs into neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fernandopulle</surname>
<given-names>Michael S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prestil</surname>
<given-names>Ryan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grunseich</surname>
<given-names>Chris</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gan</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ward</surname>
<given-names>Michael E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD</aff>
<aff id="A2">
<label>2</label>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA</aff>
<author-notes>
<fn fn-type="equal" id="FN1">
<label>*</label>
<p>These authors contributed equally</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>79</volume>
<issue>1</issue>
<fpage>e51</fpage>
<lpage>e51</lpage>
<!--elocation-id from pubmed: 10.1002/cpcb.51-->
<abstract>
<p id="P1">Accurate modeling of human neuronal cell biology has been a long-standing challenge. However, methods to differentiate human induced pluripotent stem cells (iPSCs) to neurons have recently provided experimentally tractable cell models. Numerous methods that use small molecules to direct iPSCs into neuronal lineages have arisen in recent years. Unfortunately, these methods entail numerous challenges, including poor efficiency, variable cell-type homogeneity, and lengthy, complicated, and expensive differentiation procedures. We recently developed a new method to generate stable transgenic lines of human iPSCs with doxycycline-inducible transcription factors at safe-harbor loci. Using a simple two-step protocol, these lines can be inducibly differentiated into either cortical (i<sup>3</sup>Neurons) or lower motor neurons (i<sup>3</sup>LMN) in a rapid, efficient, and scalable manner<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. In this manuscript, we describe a set of protocols to assist investigators in the culture and genetic engineering of iPSC lines to enable transcription-factor mediated differentiation of iPSCs into i<sup>3</sup>Neurons or i<sup>3</sup>LMNs, and we present neuronal culture conditions for various experimental applications.</p>
</abstract>
<kwd-group>
<kwd>iPSC</kwd>
<kwd>iPSC-derived neurons</kwd>
<kwd>transcription-factor mediated differentiation</kwd>
<kwd>i<sup>3</sup>Neurons</kwd>
<kwd>i<sup>3</sup>LMN</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>